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Summary of 2013 results 
 
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning by 
alcohol and/or other drugs, and deaths among drug users, in the period 2004–2013. The figures in this update 
supersede all previously published figures.
a
  
 
Overview 
• In the ten-year period 2004–2013 a total of 6,002 deaths by drug poisoning and deaths among drug users met 
the criteria for inclusion in the NDRDI database. Of these deaths, 3,519 were due to poisoning and 2,483 were 
deaths among drug users (non-poisoning) (Table 1). 
• The annual number of deaths in 2013 increased to 679, compared to 658 in 2012. The 2013 figure is likely to 
be revised upwards when new data become available (Table 1). 
• Median age for all deaths in 2013 was 41 years and 491 (72%) of all deaths were male.  
 
Poisoning deaths in 2013 
• The annual number of poisoning deaths increased from 361 in 2012 to 387 in 2013 (Table 1).    
• Males have accounted for the majority of deaths in each year since 2004; 68% of all poisoning deaths in 2013 
were male (Figure 1).  
• The median age of those who died in 2013 was 41 years, slightly older to previous years (Table 2). 
• Polydrugs accounted 60% of poisoning deaths (Figure 3).  
• Alcohol was involved in 35% of poisoning deaths, more than any other specific drug (Table 5).  Alcohol alone 
was responsible for 15% of poisoning deaths. 
• Methadone was implicated in a quarter of poisonings (93, 24%).  
• There were 86 deaths where heroin was implicated (22% of all poisoning deaths). This is the first time since 
2009 that the number of heroin-related deaths has increased (Table 6). 
o Over two fifths (42%) of people who died of deaths where heroin (injecting or smoking) was 
implicated were not alone at the time they took the drug, therefore there may have been an 
opportunity to prevent deaths 
o Half (49%) of those who died from a heroin-related death were known to be injecting at the time of 
their death 
o Three in 5 (62%) of deaths in 2013, where heroin was injected, occurred in a private dwelling. 
• The number of deaths where benzodiazepines were implicated increased by 24%, to 160 in 2013 compared to 
129 in 2012. Two fifths (41%) of poisonings in 2013 involved benzodiazepines (Table 7). 
• Deaths where new psychoactive substances (NPS) were implicated increased to 15 deaths compared to seven 
deaths in 2012 (Table 3). The majority (80%) of these deaths involved polydrugs. 
• Over two fifths (43%) of those who died owing to poisoning had a history of mental health illness. 
 
 
Focus on polydrug poisonings 
• Almost two thirds (60%) of poisoning deaths in 2013 involved polydrugs (Figure 3).  
• Deaths due to polydrugs have increased by 98% over the reporting period, from 118 in 2004 to 234 in 2013 
(Figure 3). 
o 57% of deaths where alcohol was implicated involved other drugs (polydrug poisonings), mainly 
benzodiazepines (Table 5). 
o 94% of deaths where methadone was implicated involved other drugs; mainly benzodiazepines. 
o 72% of deaths where heroin was implicated involved other drugs, mainly benzodiazepines (Table 7). 
• The majority (80%) of deaths where NPS were implicated involved polydrugs. The other main drugs involved in 
these poisoning deaths were cocaine, MDMA and benzodiazepines. 
 
 
                                               
a Please note that previously reported figures for the years 2004–2012 have been updated to include new data. Similarly, figures for 
2013 will be revised in the future when new data become available.  
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Non-poisoning deaths in 2013  
• The number of non-poisoning deaths recorded among drug users decreased slightly to 292, compared to 295 
in 2012 (Table 1). These deaths are categorised as being due to either trauma (n = 129) or to medical causes (n 
= 163).  
• Almost two fifths (38%) had a history of mental health illness (Figure 5). 
• Males accounted for 77% of all non-poisoning deaths in 2013. 
 
Main causes of non-poisoning deaths in 2013 
• Death due to hanging accounted for 25% (n = 74) of all non-poisoning deaths (Figure 6). 
o More than half (44, 59%) of deaths due to hanging in 2013 had a history of mental health illness. 
• The most common medical cause of death in 2013 was deaths due to cardiac events, accounting for almost a 
fifth (52, 18%) of all non-poisoning deaths (Figure 6). 
• A younger cohort died from traumatic causes (median age of 34 years) in comparison to deaths due to medical 
causes (median age of 47 years). 
 
This document may be cited as: Health Research Board (2015) Drug-related deaths and deaths among drug users in 
Ireland: 2013 figures from the National Drug-Related Deaths Index. Available at: 
www.drugsandalcohol.ie/24676 and at www.hrb.ie/publications. 
 
 
Glossary 
 
Drug users: Individuals who have a history of drug dependency or of non-dependent abuse of drugs and/or other drugs 
 
Non-poisoning deaths: Deaths in individuals with a history of drug dependency or non-dependent abuse of drugs 
(ascertained from toxicology results and from Central Treatment List, medical or coronial records) whether or not the 
use of the drug was directly implicated in the death 
 
Poisoning deaths: Deaths which are directly due to the toxic effect of the presence in the body of one or more drugs 
and/or other drug(s) 
 
Other prescription drugs:  include non-benzodiazepine sedatives such as Z drugs (esp. Zopiclone), antipsychotics, 
antiepileptic, anxiety drugs and other prescription drugs. 
 
Introduction 
 
The Irish National Drug-Related Deaths Index (NDRDI) is an epidemiological database which records cases of death by 
drug and/or alcohol poisoning, and deaths among drug users and those who are alcohol dependent. The NDRDI is 
maintained by the Health Research Board (HRB). It is jointly funded by the Department of Health and the Department 
of Justice and Equality. 
 
The NDRDI was established in September 2005 to comply with Action 67 of the 2001–2008 National Drugs 
Strategy.1 Prior to that, drug-related deaths and deaths among drug users had not been systematically documented in 
Ireland.  Families of drug users in Dublin, through the National Family Support Network (which supports the 
development of family support groups and networks in Ireland in dealing with the problem of drug misuse; www.fsn.ie) 
had advocated for some years for the development of a mechanism to accurately measure the extent of premature 
death among drug users.  In response to this, Action 67 called for the development of a system for recording drug-
related deaths and deaths among drug users to enable the State and its agencies to respond in a timely manner, with 
accurate data. The objectives of the NDRDI also include identifying and prioritising areas for intervention and 
prevention, and measuring the effects of such interventions. The remit of the NDRDI was further expanded in January 
2006 to include alcohol-related deaths and deaths of people who were alcohol dependent. 
 
The number of drug-related deaths and deaths among drug users is one of the key indicators used to measure the 
consequences of problem drug use in Europe. The NDRDI enables accurate reporting of these key data to the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
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The NDRDI records data from four sources: the Coroner Service, the Hospital In-Patient Enquiry scheme (HIPE), the 
Central Treatment List (CTL), the General Mortality Register (GMR) via the Central Statistics Office (CSO) in order to 
ensure that the database is complete and accurate. Cases from the different data sources are cross-matched on a 
selection of variables, including name, gender, county of residence, date of birth, and date of death. This allows the 
NDRDI to eliminate duplicates and to maximise the amount of information available on each case recorded on the 
database. Named data were not available from the GMR for the years 2004 and 2005; to avoid duplication and over-
estimation of the number of cases, GMR cases with no match in the other three data sources were not included in the 
NDRDI for those two years. More detailed information on the methodology can be found in the previously published 
HRB Trends Series papers.2-4  
 
 
Background 
 
Drug use can lead to premature death from a range of different causes.
5
 Many deaths are caused by poisoning (both 
intentional and unintentional), where the death is directly attributable to the consumption of drugs (alone or in 
combination with other drugs). For the purposes of this paper, this type of directly drug-related death is referred to as a 
poisoning. 
 
Deaths among drug users (whether the user is dependent or non-dependent) may be indirectly attributed to their drug 
use. For the purpose of this paper, this type of indirectly drug-related death is referred to as a non-poisoning. Causes of 
death in such cases include: 
 
• infection with HIV as a result of sharing drug paraphernalia, and subsequent development of an AIDS-related 
illness; 
• the harmful effects of drug use (both short and long term) on the health of the drug user, such as the cardio-
toxic effect of cocaine or drug-related liver disease;
6-9
 
• actions taken while under the influence of drugs, such as accidents caused by impaired judgement or 
exacerbation of risky behaviours;
5, 6
 
• psychiatric illness as a co-morbid condition, which places the individual at a greater risk of suicide.5, 10-12 
 
In line with international practice, deaths that are the result of the drug use of another individual, such as a road traffic 
collision or an assault, are not recorded by the NDRDI. 
 
Alcohol consumption has been reported as the third most detrimental risk factor for ill health and premature death in 
Europe.
13
  The NDRDI has retrospectively recorded data from 2004 onwards on alcohol-related deaths and deaths 
among those who were alcohol dependent. Poisoning deaths due to alcohol-only (collected retrospectively from 2004) 
have been included in the web-updates of 2009 data onwards, therefore data reported since then differ to previous 
NDRDI reports on poisoning deaths. This update however does not include data on non-poisoning deaths in individuals 
who had a history of alcohol dependency only.  
 
Most cases of drug misuse or dependence involve illicit drugs; however, licit drugs also may be misused and may lead to 
dependency. Deaths in which licit drugs are implicated are included in the NDRDI. A documented history of drug 
dependence or drug use is not available in all cases, leading to an under recording of the total number of non-poisoning 
deaths in the drug-using population. Calculation of mortality figures for both poisonings and non-poisonings provides 
an estimate of the total burden of mortality related to drug use in Ireland. 
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Results 
 
 
Between 2004 and 2013, 6,002 deaths by drug and alcohol poisoning and deaths among drug users met the criteria for 
inclusion in the NDRDI. Please note that previously reported figures for the years 2004–2012 have been updated to 
include new data. Similarly, figures for 2013 will be revised in the future when new data become available. The NDRDI 
submits an annual report to the EMCDDA on a subset of the data on poisoning deaths which differ to the data in this 
report. For further details see the national report; http://www.drugsandalcohol.ie/php/annual_report.php 
 
 
Table 1   Number of deaths, by year, NDRDI 2004 to 2013 (N=6,002) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
All deaths 432 505 554 622 628 658 609 657 658 679 
Poisonings (3,519) 267 300 325 389 386 374 342 388 361 387 
Non-poisonings (2,483) 165 205 229 233 242 284 267 269 297 292 
 
 
Poisoning deaths 
 
 
Figure 1   Percentage poisoning deaths, by gender and by year of death, NDRDI 2004 to 2013 (N=3,519) 
 
 
 
 
Table 2   Poisoning deaths, by median age and by gender, NDRDI 2004 to 2013 (N=3,519) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Median age in years 40 39 36 36 38 38 40 39 40 41 
Age range* 20-68 18-65 20-64 19-67 21-65 22-67 21-67 22-65 22-67 23-67 
Median age-male 36 36 35 34 36 36 37 38 38 38 
Median age-female 47 46 43 42 46 47 49 45 48 46 
*Age range presented is the 5th to the 95th percentile (90% of cases are included within this range) 
 
 
 
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Male 65.5% 66.3% 69.8% 69.7% 71.0% 68.4% 74.3% 72.7% 74.2% 68.5%
Female 34.5% 33.7% 30.2% 30.3% 29.0% 31.6% 25.7% 27.3% 25.8% 31.5%
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Figure 2   Poisoning deaths, by age band, by year NDRDI 2004 to 2013 (N=3,519) 
 
 
 
 
 
 
 
 
 
Figure 3   Single and polydrug poisoning deaths, NDRDI 2004 to 2013 (N=3,519) 
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Table 3   Multi response drug groups, NDRDI 2004 to 2013 (N=3,519)  
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 % Total 
All poisoning deaths 267 300 325 389 386 374 342 388 361 387 100 
   
 
  
 
  
 
  
 
   
  
Opiates† 131 159 182 189 218 236 191 265 227 249 58.2 
 
  
 
  
 
  
 
  
 
  
 
  
Benzodiazepines 77 79 116 124 123 134 132 254 175 234 41.1 
 
  
 
  
 
  
 
  
 
  
 
  
Alcohol 125 116 112 174 155 143 154 147 130 137 39.6 
 
  
 
  
 
  
 
  
 
  
 
  
Antidepressants 54 53 43 48 87 67 67 100 90 120 20.7 
 
  
 
  
 
  
 
  
 
  
 
  
Other prescription 
medications§ 
43 41 41 63 62 60 77 94 103 139 20.5 
 
  
 
  
 
  
 
  
 
  
 
  
Stimulants (excluding 
NPS)
ᵮ
 
32 46 62 85 68 56 22 35 38 43 13.8 
 
  
 
  
 
  
 
  
 
  
 
  
Non-opiate analgesics 13 23 11 19 18 16 15 21 23 30 5.4 
 
  
 
  
 
  
 
  
 
  
 
  
New Psychoactive 
Substances (NPS) 
~ ~ ~ ~ ~ 5 6 8 8 28 1.6 
    (Individual NPS   
deaths) 
(~) (~) (~) (~) (~) (5) (6) (5) (7) (15) (1.1) 
 
  
 
  
 
  
 
  
 
  
 
  
Others/Unknown‡ 8 23 21 24 31 44 31 31 29 34 7.8 
*This is a multi-response table taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals shown as individual 
cases may use more than one drug. 
† Includes heroin, methadone, morphine, codeine, unspecified opiate-type drug, other opiate analgesic. 
§ Includes non-benzodiazepine sedatives, anti-psychotics, Z drugs, barbiturates, cardiac and all other types of prescription medication. 
ᵮ Includes cocaine and MDMA. 
‡ includes solvents, insecticides, herbicides, other amphetamines, hallucinogens, cannabis, and other chemicals. 
~ Less than five cases. 
 
 
Of the 203 individual deaths in 2013 in which opiates were implicated, 93 deaths (46%) were not alone at the time of 
the incident. Forty six deaths had two types of opiates implicated. This accounts for the total count of 249 for all opiates 
in the multi-response table (Table 3).  
 
In 2009, once laboratory standards became available, new psychoactive substances (NPS) began to appear in drug-
related deaths. The number of deaths increased from five deaths involving NPS in 2009 to 15 deaths involving NPS in 
2013 (Table 3). The majority of these deaths involved polydrugs. The other main drugs involved in these poisoning 
deaths were cocaine, MDMA and benzodiazepines. 
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Table 4   Main specific drugs involved in poisoning deaths, NDRDI 2004 to 2013 (N=3,519)  
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 % Total 
All deaths* 267 300 325 389 386 374 342 388 361 387 100 
 
  
 
  
 
  
 
  
 
  
 
  
Alcohol 125 116 112 174 155 143 154 147 130 137 39.6 
 
  
 
  
 
  
 
  
 
  
 
  
Heroin 29 47 67 80 91 115 73 66 64 86 20.4 
Methadone 40 43 60 57 80 69 60 119 89 93 20.2 
 
  
 
  
 
  
 
  
 
  
 
  
Diazepam 31 41 64 62 65 80 68 135 92 111 21.3 
Flurazepam 18 13 23 21 20 24 28 50 29 40 6.4 
 
  
 
  
 
  
 
  
 
  
 
  
Cocaine 19 36 54 66 61 53 21 24 26 31 11.1 
MDMA 13 10 8 19 7 ~ ~ 11 12 12 2.7 
 
  
 
  
 
  
 
  
 
  
 
  
Citalopram 14 13 8 13 20 20 20 33 16 22 5.1 
 
  
 
  
 
  
 
  
 
  
 
  
Zopiclone 5 ~ 7 6 10 12 18 22 23 51 4.4 
*This is a multi-response table taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals shown as individual 
cases may use more than one drug. 
~ Less than five cases. 
 
Ninety four percent of deaths where methadone was implicated involved other drugs (87/93, 94%), mainly 
benzodiazepines. 
 
 
Table 5   Individual deaths involving alcohol and other drugs implicated, NDRDI 2004 to 2013 (N=1,393) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
All NDRDI poisonings 267 300 325 389 386 374 342 388 361 387 
 
  
 
  
 
  
 
  
 
  
 
Individual deaths where alcohol 
was implicated (% of all 
poisonings) 
125 
(46.8) 
116 
(38.7) 
112 
(34.5) 
174 
(44.7) 
155 
(40.2) 
143 
(38.2) 
154 
(45.0) 
147 
(37.9) 
130 
(36.0) 
137 
(35.4) 
 
  
 
  
 
  
 
  
 
  
 
All individual deaths involving 
alcohol 
125 116 112 174 155 143 154 147 130 137 
           
Single (%) 
61 
(48.8) 
51 
(44.0) 
56 
(50.0) 
85 
(48.9) 
81 
(52.3) 
61 
(42.7) 
79 
(51.3) 
65 
(44.2) 
76 
(58.5) 
59 
(43.1) 
 
  
 
  
 
  
 
  
 
  
 
Poly drugs involved (%) 
64 
(51.2) 
65 
(56.0) 
56 
(50.0) 
89 
(51.1) 
74 
(47.7) 
82 
(57.3) 
75 
(48.7) 
82 
(55.8) 
54 
(41.5) 
78 
(56.9) 
 
  
 
  
 
  
 
  
 
  
 
Main drugs implicated with 
alcohol* 
  
 
  
 
  
 
  
 
  
 Benzodiazepines 32 37 41 54 51 55 54 83 46 65 
Opiates 31 47 28 47 42 54 47 56 39 38 
Antidepressants 19 14 12 15 25 16 16 19 18 36 
Other prescription meds 15 5 9 13 13 13 16 23 16 29 
*This is multi-response analysis taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals shown as individual 
cases may use more than one drug. 
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Table 6   Individual deaths involving heroin and other drugs implicated, NDRDI 2004 to 2013 (N=718) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
All NDRDI poisonings 267 300 325 389 386 374 342 388 361 387 
 
  
 
  
 
  
 
  
 
  
 
Individual deaths 
where heroin was 
implicated (% of all 
poisonings) 
29 
(10.9) 
47 
(15.7) 
67 
(20.6) 
80 
(20.6) 
91 
(23.6) 
115 
(30.7) 
73 
(21.3) 
66 
(17.0) 
64 
(17.7) 
86 
(22.2) 
 
  
 
  
 
  
 
  
 
  
 
All individual deaths 
involving heroin 
29 47 67 80 91 115 73 66 64 86 
Not alone 
12 
(41.4) 
28 
(59.6) 
41 
(61.2) 
43 
(53.8) 
57 
(62.6) 
77 
(67.0) 
42 
(57.5) 
34 
(51.5) 
38 
(59.4) 
36 
(41.9) 
 
  
 
  
 
  
 
  
 
  
 
Poly drugs involved 
11 
(37.9) 
30 
(63.8) 
40 
(59.7) 
56 
(70.0) 
66 
(72.5) 
75 
(65.2) 
43 
(58.9) 
53 
(80.3) 
55 
(85.9) 
62 
(72.1) 
 
  
 
  
 
  
 
  
 
  
 
Injecting at time of 
death; 
22 
(75.9) 
30 
(63.8) 
44 
(65.7) 
41 
(51.3) 
43 
(47.3) 
51 
(44.3) 
39 
(53.4) 
35 
(53.0) 
28 
(43.8) 
42 
(48.8) 
Of whom died in 
private dwelling 
10 15 20 19 28 32 26 30 17 26 
 
  
 
  
 
  
 
  
 
  
 
Main drugs 
implicated with 
heroin* 
  
 
  
 
  
 
  
 
  
 Benzodiazepines 9 17 27 34 40 48 29 66 59 70 
Other opiates 5 11 14 16 20 30 11 27 25 32 
Other prescription 
meds 
~ ~ ~ 5 11 10 8 5 17 19 
Alcohol ~ 12 12 27 24 24 18 16 15 18 
*This is multi-response analysis taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals shown as individual 
cases may use more than one drug. 
~ Less than five cases. 
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Of the 160 individual deaths in 2013 in which benzodiazepines were implicated, 61 deaths involved two or more types 
of benzodiazepine (Table 7). However, the total count for all benzodiazepines in the multi-response table is equal to 
234 (Table 4). 
 
Table 7   Total number of deaths where any benzodiazepine and other drugs implicated, NDRDI 2004 to 
2013 (N=1,100)    
 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
All NDRDI poisonings 267 300 325 389 386 374 342 388 361 387 
 
  
 
  
 
  
 
  
 
  
 
Individual deaths where BZD 
implicated (% of all poisonings) 
64 
(24) 
65 
(21.7) 
91 
(28) 
97 
(24.9) 
103 
(26.7) 
113 
(30.2) 
105 
(30.7) 
173 
(44.6) 
129 
(35.7) 
160 
(41.3) 
 
  
 
  
 
  
 
  
 
  
 
All individual deaths involving 
benzodiazepines (BZD) 
 64 65 91  97 103  113 105  173 129  160 
 
  
 
  
 
  
 
  
 
  
 
Poly drugs involved 61 64 88 95 103 112 105 170 127 158 
 
  
 
  
 
  
 
  
 
  
 
More than one BZD implicated 13 11 21 22 18 21 25 70 41 61 
 
  
 
  
 
  
 
  
 
  
 Main drugs implicated with  
BZDs*   
 
  
 
  
 
  
 
  
 Opiates: 48 56 76 67 89 103 87 175 139 159 
methadone 21 18 33 27 36 41 34 85 61 70 
heroin 6 15 21 27 33 40 23 44 44 47 
Alcohol 28 25 29 40 38 30 36 69 54 83 
Antidepressants 27 17 22 18 38 30 35 60 45 76 
*This is multi-response analysis taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals shown as individual 
cases may use more than one drug. 
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Table 8   Poisoning deaths, by drugs and alcohol task force area where deceased resided, NDRDI 2004 to 
2013 (N=3,519)  
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
North Eastern  RDATF 18 20 23 28 29 22 23 44 30 45 
Mid West  RDATF 15 18 13 18 19 37 30 25 19 32 
South East RDATF 26 23 22 40 40 33 37 34 44 30 
Midlands  RDATF 12 15 17 17 21 26 19 26 15 26 
Western  RDATF 17 19 17 33 23 23 21 19 17 25 
Cork LDATF 14 12 20 27 13 19 14 10 26 23 
North Dublin City and County  
RDATF 10 14 12 15 12 20 20 20 13 22 
North West  RDATF 14 13 10 8 13 17 7 11 21 21 
North Inner City LDATF 14 18 13 14 24 19 21 30 20 19 
Finglas-Cabra LDATF ~ 9 6 6 12 10 7 6 10 18 
Southern  RDATF 19 22 22 31 31 24 19 37 27 17 
South Western  RDATF 11 14 17 19 23 19 24 25 18 15 
Dun Laoghaire-Rathdown LDATF 16 13 16 17 14 13 19 6 11 13 
Clondalkin LDATF 9 10 6 ~ 9 6 6 5 6 13 
Dublin North East LDATF 9 10 25 19 16 10 7 10 15 12 
Tallaght LDATF 7 7 9 5 8 15 11 9 14 9 
Dublin South Inner City LDATF 7 8 19 21 13 13 11 20 13 8 
Ballymun LDATF 8 6 10 5 7 10 5 6 ~ 6 
Dublin 12 LDATF 11 6 ~ 9 11 ~ ~ ~ ~ 6 
Blanchardstown LDATF ~ 5 5 ~ 5 ~ ~ 6 ~ 5 
Canal Communities LDATF ~ ~ ~ ~ ~ ~ ~ ~ ~ 5 
Bray LDATF ~ ~ ~ ~ ~ ~ ~ ~ 5 5 
Ballyfermot LDATF 5 ~ 7 6 7 ~ ~ ~ ~ ~ 
East Coast  RDATF 6 19 11 10 11 ~ 12 8 ~ ~ 
Other/unknown 8 11 19 30 19 18 13 18 16 9 
~ Less than five cases. 
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Non-poisoning deaths 
 
Of the 2,483 non-poisoning deaths in the period 2004–2013, the category of death was known for 2,398 (97%), of which 
1,230 were due to traumatic causes and 1,168 were due to medical causes.  These figures do not include deaths among 
alcohol-dependent people who were not drug users.  
 
 
Figure 4   Non-poisoning deaths among drug users, NDRDI 2004 to 2013 (N=2,398) 
 
 
 
 
Figure 5   Non-Poisoning deaths among drug users, by history of mental health illness, NDRDI 2010 to 2013 
(N=1,124) 
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Figure 6  Non-Poisoning deaths among drug users, by main type of death, NDRDI 2004 to 2013 (N=1,748) 
 
 
 
Figure 7    Non-Poisoning deaths among drug users, by age group, by gender, NDRDI 2013 only (N=292) 
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Table 9 Non-Poisoning deaths by drugs and alcohol task force area where deceased resided, NDRDI 2004 
to 2013 (N=2,483) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Dun Laoghaire-Rathdown LDATF 5 12 11 6 8 9 11 6 13 27 
Tallaght LDATF ~ 7 6 ~ 6 13 7 15 6 20 
Dublin South Inner City LDATF 13 13 10 14 17 19 18 18 24 19 
North Inner City LDATF 18 17 24 21 20 22 26 18 14 18 
Cork LDATF 6 9 10 11 7 25 18 10 16 18 
North Dublin City and County  
RDATF 
7 ~ 7 7 8 12 8 13 14 18 
South Western  RDATF 10 ~ 11 12 5 8 8 22 19 17 
Southern  RDATF 6 10 13 16 15 11 25 20 16 15 
Western  RDATF 6 6 10 5 6 15 8 ~ 11 15 
South East RDATF 8 12 12 12 20 14 14 17 28 15 
Dublin North East LDATF 7 11 10 8 13 7 10 10 15 14 
Mid West  RDATF 11 11 5 15 16 14 12 17 13 14 
Midlands  RDATF ~ ~ 10 ~ 9 10 16 11 9 13 
North Eastern RDATF 11 16 11 14 13 16 16 21 25 12 
North West RDATF ~ 9 5 8 10 6 ~ 6 5 10 
Finglas-Cabra LDATF 5 10 13 18 15 19 14 6 12 9 
Clondalkin LDATF ~ 9 8 ~ 7 7 ~ 9 12 8 
Canal Communities LDATF ~ ~ ~ ~ ~ 5 ~ ~ 8 7 
Dublin 12 LDATF 6 11 6 7 10 5 6 11 8 6 
Blanchardstown LDATF 7 ~ ~ ~ ~ ~ ~ ~ 5 ~ 
Ballyfermot LDATF 8 ~ 5 12 5 12 10 5 7 ~ 
Bray LDATF ~ 5 ~ ~ ~ ~ ~ ~ ~ ~ 
East Coast  RDATF ~ ~ 9 5 ~ 5 7 ~ 6 ~ 
Ballymun LDATF ~ ~ ~ 5 ~ 6 ~ 6 ~ ~ 
Other/unknown 10 14 22 20 20 17 14 11 8 ~ 
~ Less than five cases. 
 
 
  
14 
 
References 
 
1. Department of Tourism Sport and Recreation (2001) Building on experience: National Drugs Strategy 2001–2008. 
Dublin: Stationery Office. 
2. Lynn E, Lyons S, Walsh S and Long J (2009) Trends in deaths among drug users in Ireland from traumatic and medical 
causes, 1998 to 2005. HRB Trends Series 8. Dublin: Health Research Board. 
3. Lyons S, Lynn E, Walsh S and Long J (2008) Trends in drug-related deaths and deaths among drug users in Ireland, 
1998 to 2005. HRB Trends Series 4. Dublin: Health Research Board. 
4. Bellerose D, Lyons S, Carew AM, Walsh S and Long J (2010) Problem benzodiazepine use in Ireland: treatment (2003 
to 2008) and deaths (1998 to 2007). HRB Trends Series 9. Dublin: Health Research Board. 
5. Darke S, Degenhardt L and Mattick R (2007) Mortality amongst illicit drug users: epidemiology, causes and 
intervention. Cambridge: Cambridge University Press. 
6. Webb L, Oyefeso A, Schifano F, Cheeta S, Pollard M and Ghodse HA (2003) Cause and manner of death in drug-
related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000. Drug and 
Alcohol Dependence, 72(1): 67–74. 
7. Darke S, Kaye S and Duflou J (2004) Cocaine-related fatalities in New South Wales, Australia 1993–2002. Drug and 
Alcohol Dependence, 77(2): 107–114. 
8. Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P (2001) Study of 2708 heroin-related deaths in 
north-eastern Italy 1985–98 to establish the main causes of death. Addiction, 96(6): 1127–1137. 
9. Karch S (2002) Karch's pathology of drug abuse. 3rd edition. Boca Raton, FL: CRC Press. 
10. Baldacchino A and Corkery J (2006) Comorbidity: perspectives across Europe. London: European Collaborating 
Centres in Addition Studies. 
11. Darke S, Duflou J and Torok M (2009) Toxicology and circumstances of completed suicide by means other than 
overdose. Journal of Forensic Sciences, 54(2): 490–494. 
12. Farrell M, Neeleman J, Griffiths P and Strang J (1996) Suicide and overdose among opiate addicts. Addiction, 91(3): 
321–323. 
13. WHO (2002) The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health 
Organization.  
 
Acknowledgements 
 
The NDRDI would like to express sincere thanks to all those who contribute to the NDRDI, in particular NDRDI staff, the 
staff of the Coroner Service, Forensic and Legal Medicine UCD, HIPE, CSO and CTL.  We also would like to thank the CSO 
for their assistance in the provision of data and for facilitating NDRDI's access to the data.  All the co-operation and 
assistance is very much appreciated and valued.   
 
For further information on the NDRDI please contact Ena Lynn (01 2345155), Suzi Lyons (01 2345163) or ndrdi@hrb.ie. 
 
